Search research articles
Contact Us
Filters
Showing results (261-270 of 661) with videos related to
Page
of 67
Sort By:
Fortune
|
September 11, 2004
Baxter's healthy return. Morgan Stanley's Glenn Reicin says the medical products company's prognosis is finally positive
David Stires
Fortune
|
May 19, 2004
One family's cause may cure a disease
Cora Daniels
Fortune
|
May 19, 2004
Is nanotech ready for its close-up?
Nicholas Varchaver
Fortune
|
August 3, 2012
Replacing the mouse
J P Mangalindan
Fortune
|
May 6, 2004
Growing against the grain
Matthew Boyle
Fortune
|
April 21, 2004
Caloric restriction. Extreme makeover. Eating like a bird may extend your life. But is it worth it?
Grainger David
Fortune
|
July 9, 2005
Look out below! five threats to your financial security
Cait Murphy, Julia Boorstin
Fortune
|
June 25, 2005
Therapy that gets inside your head--literally
John Simons
Fortune
|
June 30, 2005
The dogged scientist, the old lab vial, and the quest to stop cancer
David Stipp
Fortune
|
June 2, 2005
A new CEO'S RX for what ails Merck
John Simons
Page
of 67
Search research articles
Search
Showing results (261-270 of 661) with videos related to
Sort By:
Page
of 67
Fortune
|
September 11, 2004
Baxter's healthy return. Morgan Stanley's Glenn Reicin says the medical products company's prognosis is finally positive
David Stires
Fortune
|
May 19, 2004
One family's cause may cure a disease
Cora Daniels
Fortune
|
May 19, 2004
Is nanotech ready for its close-up?
Nicholas Varchaver
Fortune
|
August 3, 2012
Replacing the mouse
J P Mangalindan
Fortune
|
May 6, 2004
Growing against the grain
Matthew Boyle
Fortune
|
April 21, 2004
Caloric restriction. Extreme makeover. Eating like a bird may extend your life. But is it worth it?
Grainger David
Fortune
|
July 9, 2005
Look out below! five threats to your financial security
Cait Murphy, Julia Boorstin
Fortune
|
June 25, 2005
Therapy that gets inside your head--literally
John Simons
Fortune
|
June 30, 2005
The dogged scientist, the old lab vial, and the quest to stop cancer
David Stipp
Fortune
|
June 2, 2005
A new CEO'S RX for what ails Merck
John Simons
Page
of 67